Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other 1

Conditions

Obesity 45Mucositis 29Neoplasms 23Sexual Dysfunction, Physiological 19Head and Neck Neoplasms 16Breast Neoplasms 16Opioid-Induced Constipation 12Dyspnea 11Constipation 11Pain 10Polycystic Ovary Syndrome 9Weight Loss 7Squamous Cell Carcinoma of Head and Neck 7Prostatic Neoplasms 7Motor Activity 7Diabetes Mellitus 7Cardiovascular Diseases 6Xerostomia 5Stomatitis 5Radiation Injuries 5Overweight 5Sedentary Behavior 4Endometrial Neoplasms 4Diabetes Mellitus, Type 2 4Colorectal Neoplasms 4Bronchiolitis Obliterans Syndrome 4Sexuality 3Salivary Gland Neoplasms 3Hypertension 3Fatty Liver 3

Interventions

methylnaltrexone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Opioid-Related Disorders × Other × Clear all
NCT01004393 2016-02-02

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

University of Vermont

Phase 2 Completed
12 enrolled 10 charts
Other

Constipation, Opioid-Related Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡